Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Barinthus Biotherapeutics (BRNS) Short-term Investments (2024 - 2025)

Barinthus Biotherapeutics' Short-term Investments history spans 2 years, with the latest figure at $1.4 million for Q4 2025.

  • For Q4 2025, Short-term Investments fell 19.68% year-over-year to $1.4 million; the TTM value through Dec 2025 reached $1.4 million, down 19.68%, while the annual FY2025 figure was $1.4 million, 19.68% down from the prior year.
  • Short-term Investments reached $1.4 million in Q4 2025 per BRNS's latest filing, roughly flat from $1.4 million in the prior quarter.
  • In the past five years, Short-term Investments ranged from a high of $1.7 million in Q4 2024 to a low of $1.4 million in Q4 2025.